# RNN 1st Gen Model Walgreens Boots Alliance, Inc. Drug stores & proprietary stores

Stock predictor AI models:
66.67% successful of 30 deals
$ 47.02 Last close price
at 29-oct-2021


Model's trade recommendations 1.58% Return for period

-1.06% Annual return

$63.12B Market Cap

β 1.15  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 1.58%
52wk return -4.21%
52wk Range
Sortino ratio -0.19
Sharpe ratio -0.16
Norm. RMSE 0.71%
Downside risk 6.08%
Volatility 0.00%
  • 1.60 (2.51%) Div (Yield)
  • BUY Analysts consensus recommendation

Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.

Industry sector: Retail/Wholesale

Sector classification: Drug stores & proprietary stores

Deep Learning based analysis and prediction model for Walgreens Boots Alliance, Inc. (WBA) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for WBA model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for WBA.

Model is being retrained on a daily basis.

Float 845M
P/E 11.27
Shares Outstanding 992M
% Held by Insiders 14.80%
% Held by Institutions 60.92%
EPS (last reported FY) $5.10
EPS (last reported Q) $1.73
EPS, estimated (last reported Q) $1.55
Total revenues $118 B
Net income $4 B